Abstract
Isothiazolinones are used in cosmetic and chemical substances for occupational use and possess bacteriostatic and fungiostatic activity. Isothiazolinones are potent contact allergens. The use of the isothiazolinone methylchloroisothiazolinone (MCI) in 3:1 combination with methylisothiazolinone (MI) (MCI/MI) resulted in the 1980s in high prevalence rates of contact allergy to MCI/MI across the EU. This rapid increase in new cases of MCI/MI contact allergy instigated a restriction of MCI/MI to 15 ppm that subsequently resulted in decreasing prevalence rates of contact allergy to MCI/MI in the EU. Later, around the millennium, MI was introduced as a single preservative in chemical substances for occupational use, and in 2005 and onward, MI was introduced in cosmetic products as a single preservative. The use of MI has resulted in an unprecedented steep increase in new cases of contact allergy to MI on the European continent, the US, Asia, and Australia. In many countries, the prevalence rates of MI exceed 7–10%. These two epidemics have mainly been driven by use of MCI/MI and MI in cosmetic products, but both are as well important allergens in the work environment. Occupations at special risk for MCI/MI or MI sensitization are painters, blacksmiths, machine operators, cosmetologists, and tile setters.
Other isothiazolinones, e.g., benzisothiazolinone (BIT) and octylisothiazolione (OIT), are only used in industrial products and non-cosmetic consumer products such as paints and leather products and also pose a problem in special occupations.
References
Aalto-Korte K, Suuronen K (2017) Patterns of concomitant allergic reactions in patients suggest cross-sensitization between octylisothiazolinone and methylisothiazolinone. Contact Dermatitis 77:385. https://doi.org/10.1111/cod.12855. [Epub ahead of print]
Aalto-Korte K, Ackermann L, Henriks-Eckerman ML, Valimaa J, Reinikka-Railo H, Leppanen E, Jolanki R (2007) 1,2-benzisothiazolin-3-one in disposable polyvinyl chloride gloves for medical use. Contact Dermatitis 57:365–370
Aerts O, Cattaert N, Lambert J, Goossens A (2013) Airborne and systemic dermatitis, mimicking atopic dermatitis, caused by methylisothiazolinone in a young child. Contact Dermatitis 68(4):250–251
Aerts O, Baeck M, Constandt L, Dezfoulian B, Jacobs MC, Kerre S, Lapeere H, Pierret L, Wouters K, Goossens A (2014) The dramatic increase in the rate of methylisothiazolinone contact allergy in Belgium: a multicentre study. Contact Dermatitis 71:41–48
Aerts O, Meert H, Romaen E, Leysen J, Matthieu L, Apers S, Lambert J, Goossens A (2016) Octylisothiazolinone, an additional cause of allergic contact dermatitis caused by leather: case series and potential implications for the study of cross-reactivity with methylisothiazolinone. Contact Dermatitis 75:276–284
Alomar A (1981) Contact dermatitis from benzisothiazolone in cutting oils. Contact Dermatitis 7:155–156
Amsler E, Aerts O, Raison-Peyron N, Debons M, Milpied B, Giordano-Labadie F, Waton J, Ferrier-Le Bouëdec MC, Lartigau I, Pecquet C, Assier H, Avenel-Audran M, Bernier C, Castelain F, Collet E, Crépy MN, Genillier N, Girardin P, Pralong P, Tetart F, Vital-Durand D, Soria A, Barbaud A (2017) Dermatology Allergy Group (DAG) of the French Society of Dermatology. Airborne allergic contact dermatitis caused by isothiazolinones in water-based paints: a retrospective study of 44 cases. Contact Dermatitis 77:163. https://doi.org/10.1111/cod.12795. [Epub ahead of print]
Basketter D, Wright Z, Walters T, Boman A, Lidén C (2003) Biocides: characterization of the allergenic hazard of methylisothiazolinone. Cutan Ocul Toxicol 22:187–199
Bjorkner B, Bruze M, Dahlquist I, Fregert S, Gruvberger B, Persson K (1986) Contact allergy to the preservative Kathon CG. Contact Dermatitis 14:85–90
Breuer K, Uter W, Geier J (2015) Epidemiological data on airborne contact dermatitis - results of the IVDK. Contact Dermatitis 73:239–247
Bruze M, Gruvberger B, Persson K (1987) Contact allergy to a contaminant in Kathon CG in the guinea pig. Derm Beruf Umwelt 35:165–168
Bruze M, Gruvberger B, Agrup G (1988) Sensitization studies in the guinea pig with the active ingredients of Euxyl K 400. Contact Dermatitis 18:37–39
Bruze M, Engfeldt M, Gonçalo M, Goossens A (2013) Recommendation to include methylisothiazolinone in the European baseline patch test series – on behalf of the European Society of Contact Dermatitis and the European Environmental and Contact Dermatitis Research Group. Contact Dermatitis 69(5):263–270
Bruze M, Goossens A, Isaksson M (2014) Recommendation to increase the test concentration of methylchloroisothiazolinone/methylisothiazolinone in the European baseline patch test series - on behalf of the European Society of Contact Dermatitis and the European Environmental and Contact Dermatitis Research Group. Contact Dermatitis 71(1):35–40
Bruze M, Uter W, Gonçalo M, Lepoittevan J-P, Diepgen T, Orton D (2015) Incompetence and failure to regulate methylisothiazolinone. Contact Dermatitis 72:353–354
Cronin E, Hannuksela M, Lacapelle JM, Maibach H, Malten K, Meninghini C (1988) Frequency of sensitisation to the preservative Kathon CG. Contact Dermatitis 18:274–279
Damstra RJ, Van Vlotten WA, Van Ginkel CJ (1992) Allergic contact dermatitis from the preservative 1,2-benzisothiazolin-3-one (1,2-BIT; Proxel): a case report, its prevalence in those occupationally at risk and in the general dermatological population, and its relationship to allergy to its analogue Kathon CG. Contact Dermatitis 27:105–109
Debeuckelaere C, Moussallieh FM, Elbayed K, Namer IJ, Berl V, Giménez-Arnau E, Lepoittevin J-P (2016) In situ chemical behaviour of methylisothiazolinone (MI) and methylchloroisothiazolinone (MCI) in reconstructed human epidermis: a new approach to the cross-reactivity issue. Contact Dermatitis 74:159–167
de Groot AC, Herxheimer A (1989) Isothiazolinone preservative: cause of a continuing epidemic of cosmeticdermatitis. Lancet 1:314–316
Dias M, Lamarao P, Vale T (1992) Occupational contact allergy to 1,2-benzisothiazolin-3-one in the manufacture of air fresheners. Contact Dermatitis 27:205–207
European Chemicals Agency (ECHA) (2011) Guidance on labelling and packaging in accordance with regulation (EC) No. 1272/2008, Reference ECHA-11-G-04-EN 2011 April. Available at: https://echa.europa.eu/documents/10162/13562/clp_labelling_en.pdf. Last accessed 31 July 2017
European Chemicals Agency (ECHA) (2016) Guidance on labelling and packaging in accordance with regulation (EC) No. 1272/2008, Reference ECHA-16- G-05- EN 2016 April. Available at: https://echa.europa.eu/documents/10162/23036412/clp_labelling_en.pdf/89628d94-573a-4024-86cc-0b4052a74d65. Last accessed 31 July 2017
European Chemicals Agency (ECHA RAC) (2016) Committee for risk assessment, RAC. Opinion, proposing harmonised classification and labelling at EU level of 2-methylisothiazol- 3(2H)-one (ISO), Adopted 10 March 2016. Available at: https://echa.europa.eu/documents/10162/b32e77aa-b720-4f66-ad16-a413dadf1631. Last accessed 31 July 2017
European Commission (EC). Official journal of the European Union. Regulations. Commission regulation (EU) 2016/1198 of 22 July 2016 amending Annex V to Regulation (EC) No 1223/2009 of the European Parliament and of the council on cosmetic products. Published 23 July 2016. Available at: http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32016R1198&from=EN. Last accessed 1 Aug 2017
Fischer T, Bohlin S, Edling C, Rystedt I, Wieslander G (1995) Skin disease and contact sensitivity in house painters using water-based paints, glues and putties. Contact Dermatitis 32:39–45
Flyvholm MA (2005) Preservatives in registered chemical products. Contact Dermatitis 53:27–32
Fransway AF (1988) Sensitivity to Kathon CG findings in 365 consecutive patients. Contact Dermatitis 19:342–347
Freeman S (1984) Allergic contact dermatitis due to 1,2-benzisothiazolin-3-one in gum arabic. Contact Dermatitis 11:146–149
Friis UF, Menné T, Flyvholm MA, Bonde JP, Lepoittevin JP, Le Coz CJ, Johansen JD (2014) Isothiazolinones in commercial products at Danish workplaces. Contact Dermatitis 71(2):65–74
Frosch P, Schulze-Dirks A (1987) Kontaktallergie uaf Kathon CG. Hautarzt 38:422–425
Fuchs T (1986) Aktuelle Kontaktallergene und ihre Perspektiven. Med Welt 37:1305–1307
Gallo R, Signori A, Gervasio S, Riva S, Parodi A (2016) Methylisothiazolinone contact allergy – are rinse-off cosmetics and household products relevant sources of exposure? Contact Dermatitis 75:319–321
Gameiro A, Coutinho I, Ramos L, Gonçalo M (2014) Methylisothiazolinone: second ‘epidemic’ of isothiazolinone sensitization. Contact Dermatitis 70:242–243
García-Gavín J, Vansina S, Kerre S, Naert A, Goossens A (2010) Methylisothiazolinone, an emerging allergen in cosmetics? Contact Dermatitis 63(2):96–101
Garcia-Hidalgo E, Sottas V, Von Goetz N, Hauri U, Bogdal C, Hungerbuhler K (2017) Occurrence and concentrations of isothiazolinones in detergents and cosmetics in Switzerland. Contact Dermatitis 76:96–106
Geier J, Schnuch A (1996) No cross-reactivity between MCI/MI, benzisothiazolinone and octylisothiazolinone. Contact Dermatitis 34:148–149
Geier J, Lessmann H, Schnuch A, Uter W (2012) Recent increase in allergic reactions to methylchloroisothiazolinone/methylisothiazolinone: is methylisothiazolinone the culprit? Contact Dermatitis 67:334–341
Geier J, Lessmann H, Schnuch A, Uter W (2015) Concomitant reactivity to methylisothiazolinone, benzisothiazolinone, and octylisothiazolinone. International Network of Departments of Dermatology data, 2009–2013. Contact Dermatitis 72:337–339
Gonçalo M, Goossens A (2013) Whilst Rome burns: the epidemic of contact allergy to methylisothiazolinone. Contact Dermatitis 68:257–258
Gruvberger B, Bruze M, Almgren G (1998) Occupational dermatoses in a plant producing binders for paints and glues. Contact Dermatitis 38:71–77
Hannuksela M (1987) Rapid increase in contact allergy to Kathon CG in Finland. Contact Dermatitis 17:299–302
Hardcastle NJ, Gawkrodger DJ (2005) Occupational contact dermatitis to 2-benzisothiazolin-3-one and 5-chloro-2-methylisothiazolin-3-one/2-methylisothiazolin-3-one in paint manufactures. Contact Dermatitis 53:115–116
Hjorth N, Roed-Petersen J (1986) Patch test sensitivity to Kathon CG. Contact Dermatitis 14:155–157
Hosteing S, Meyer N, Waton J, Barbaud A, Bourrain JL, Raison-Peyron N, Felix B, Milpied-Homsi B, Ferrier Le Bouedec MC, Castelain M, Vital-Durand D, Debons M, Collet E, Avenel-Audran M, Mathelier-Fusade P, Vermeulen C, Assier H, Gener G, Lartigau-Sezary I, Catelain-Lamy A, Giordano-Labadie F (2014) Outbreak of contact sensitization to methylisothiazolinone: an analysis of French data from the REVIDAL-GERDA network. Contact Dermatitis 70:262–269
Isaksson M, Persson L (2015) “Mislabelled” make-up remover wet wipes as a cause of severe, recalcitrant facial eczema. Contact Dermatitis 73:56–59
Isaksson M, Gruvberger B, Bruze M (2004) Occupational contact allergy and dermatitis from methylisothiazolinone after contact with wallcovering glue and after a chemical burn from a biocide. Dermatitis 15:201–205
Isaksson M, Bruze M, Gruvberger B (2008) Cross-reactivity between methylchloroisothiazolinone/methylisothiazolinone, methylisothiazolinone, and other isothiazolinones in workers at a plant producing binders for paints and glues. Contact Dermatitis 58:60–62
Isaksson M, Ale I, Andersen KE, Elsner P, Goh CL, Goossens A, Jerajani H, Matsunaga K, McFadden J, Bruze M (2017) Multicenter patch testing with methylisothiazolinone and methylchloroisothiazolinone/methylisothiazolinone within the International Contact Dermatitis Research Group. Dermatitis 28(3):210–214. https://doi.org/10.1097/DER.0000000000000272
Johansen JD, Aalto-Korte K, Agner T, Andersen KE, Bircher A, Bruze M, Cannavo A, Giménez- Arnau A, Gonçalo M, Goossens A, John SM, Lidén C, Lindberg M, Mahler V, Matura M, Rustemeyer T, Serup J, Spiewak R, Thyssen JP, Vigan M, White IR, Wilkinson M, Uter W (2015) European Society of Contact Dermatitis guideline for diagnostic patch testing – recommendations on best practice. Contact Dermatitis 73:195–221
Johnston GA, Contributing Members of the British Society for Cutaneous Allergy (BSCA) (2014) The rise in prevalence of contact allergy to methylisothiazolinone in the British Isles. Contact Dermatitis 70:238–240
Lammintausta K, Aalto-Korte K, Ackerman L, Alanko K, Berry P, Hasan T, Kaminska R, Korhonen L, Laukkanen A, Liippo J, Pesonen M, Rantanen T, Riekki R, Suuronen K (2014) An epidemic of contact allergy to methylisothiazolinone in Finland. Contact Dermatitis 70:184–185
Lundov MD, Thyssen JP, Zachariae C, Johansen JD (2010) Prevalence and cause of methylisothiazolinone contact allergy. Contact Dermatitis 63:164–167
Lundov MD, Opstrup MS, Johansen JD (2013) Methylisothiazolinone contact allergy – growing epidemic. Contact Dermatitis 69(5):271
Lundov MD, Kolarik B, Bossi R, Gunnarsen L, Johansen JD (2014) Emission of isothiazolinones from water-based paints. Environ Sci Technol 48(12):6989–6994
Madsen JT, Broesby-Olsen S, Andersen KE (2014) Undisclosed methylisothiazolinone in an ultrasound gel causing occupational allergic contact dermatitis. Contact Dermatitis 71:312–313
Madsen JT, Andersen KE, Nielsen DT, Hvid L, El-Houri RB, Christensen LP (2016) Undisclosed presence of methylisothiazolinone in ‘100% natural’ Konjac(R) sponge. Contact Dermatitis 75:308–309
Magnano M, Silvani S, Vincenzi C, Nino M, Tosti A (2009) Contact allergens and irritants in household washing and cleaning products. Contact Dermatitis 61:337–341
Meding B, Ahman M, Karlberg AT (1996) Skin symptoms and contact allergy in woodwork teachers. Contact Dermatitis 34:185–190
Menné T, Hjorth N (1988) Kathon CG reactivity in 1396 consecutively patch tested patients in the Copenhagen area. Contact Dermatitis 19:260–262
Meysman T, Goossens A (2017) Occupational allergic contact dermatitis caused by benzisothiazolinone in printing ink and soap. Contact Dermatitis 76:51–53
Mose AP, Lundov MD, Zachariae C, Menné T, Veien NK, Laurberg G, Kaaber K, Avnstorp C, Andersen KE, Paulsen E, Mortz CG, Sommerlund M, Danielsen A, Thormann J, Kristensen O, Kristensen B, Andersen BL, Vissing S, Nielsen NH, Johansen JD (2012) Occupational contact dermatitis in painters: an analysis of patch test data from the Danish Contact Dermatitis Group. Contact Dermatitis 67:293–297
Mose AP, Frost S, Ohlund U, Andersen KE (2013) Allergic contact dermatitis from octylisothiazolinone. Contact Dermatitis 69:49–52
Reinhard E, Waeber R, Niederer M, Maurer T, Maly P, Scherer S (2001) Preservation of products with MCI/MI in Switzerland. Contact Dermatitis 45:257–264
Roberts DL, Messenger AG, Summerly R (1981) Occupational dermatitis due to 1,2-benzisothiazolin-3-one in the pottery industry. Contact Dermatitis 7:145–147
Sanz-Gallén P, Planas J, Martinez P, Giménez-Arnau JM (1992) Allergic contact dermatitis due to 1,2-benzisothiazolin-3-one in paint manufacture. Contact Dermatitis 27:271–272
Schnuch A, Mildau G, Kratz EM, Uter W (2011) Risk of sensitization to preservatives estimated on the basis of patch test data and exposure, according to a sample of 3541 leave-on products. Contact Dermatitis 65:167–174
Schwensen JF, Thyssen JP (2016) Contact allergy to preservatives–is the European Commission a commendable risk manager? Cosmetics 3:29
Schwensen JF, Menné T, Andersen KE, Sommerlund M, Johansen JD (2014) Occupations at risk of developing contact allergy to isothiazolinones in Danish contact dermatitis patients: results from a Danish multicentre study (2009–2012). Contact Dermatitis 71:295–302
Schwensen JF, Lundov MD, Bossi R, Banerjee P, Giménez-Arnau E, Lepoittevin JP, Lidén C, Uter W, Yazar K, White IR, Johansen JD (2015a) Methylisothiazolinone and benzisothiazolinone are widely used in paint: a multicentre study of paints from five European countries. Contact Dermatitis 72(3):127–138
Schwensen JF, Menné T, Friis UF, Johansen JD (2015b) Undisclosed methylisothiazolinone in wet wipes for occupational use causing occupational allergic contact dermatitis in a nurse. Contact Dermatitis 73:182–184
Schwensen JF, White IR, Thyssen JP, Menné T, Johansen JD (2015c) Failures in risk assessment and risk management for cosmetic preservatives in Europe and the impact on public health. Contact Dermatitis 73:133–141
Schwensen JF, Uter W, Magnus B, Svedman C, Goossens A, Wilkinson M, Giménez Arnau A, Gonçalo M, Andersen KE, Paulsen E, Agner T, Foti C, Aalto-Korte K, Johansen JD (2017a) The epidemic of methylisothiazolinone: a European prospective study. Contact Dermatitis 76:272–279
Schwensen JF, Menné Bonefeld C, Zachariae C, Agerbeck C, Petersen TH, Geisler C, Bollmann UE, Bester K, Johansen JD (2017b) Cross-reactivity between methylisothiazolinone, octylisothiazolinone and benzisothiazolinone using a modified local lymph node assay. Br J Dermatol 176:176–183
Scientific Committee on Consumer Safety (SCCS). Opinion on methylisothiazolinone (P94) – submission III. Adopted on 15 December 2015, SCCS/1557/15. Available at: http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_178.pdf. Last accessed 1 Aug 2017
Shuster S, Spiro J (1987) Measurement of risk of sensitisation and its application to kathon. Contact Dermatitis 17:299–302
Slovak AJ (1980) Contact dermatitis due to benzisothiazolone in a works analytical team. Contact Dermatitis 6:187–190
Taran JM, Delaney TA (1997) Allergic contact dermatitis to 1,2-benzisothiazolin-3-one in the carpet industry. Australas J Dermatol 38:42–43
The Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers (SCCNFP) (2003) Opinion concerning methylisothiazolinone (Colipa No. P94). Adopted on 18 March 2003, SCCNFP/0625/02. Available at: http://ec.europa.eu/health/archive/ph_risk/committees/sccp/documents/out_201.pdf. Accessed 22 May 2018
The Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers (SCNNFP) (2004) Opinion Concerning Methylisothiazolinone (Colipa No. P94). Adopted on 23 April 2004, SCCNFP/0805/04. Available at: http://ec.europa.eu/health/ph_risk/committees/sccp/documents/out270_en.pdf. Accessed 22 May 2018
Thomsen AV, Schwensen JF, Bossi R, Banerjee P, Giménez-Arnau E, Lepoittevin JP, Lidén C, Uter W, White IR, Johansen JD (2017) Isothiazolinones are still widely used in paints purchased in five European countries: a follow-up study. Contact Dermatitis
Thyssen JP, Sederberg-Olsen N, Thomsen JF, Menné T (2006) Contact dermatitis from methylisothiazolinone in a paint factory. Contact Dermatitis 54:322–324
Tosti A (1988) Prevalence and sources of Kathon CG sensitization in Italy. Contact Dermatitis 18:173–174
Urwin R, Craig S, Latheef F, Wilkinson M (2017) Methylisothiazolinone: the epidemic is declining – but not gone. Contact Dermatitis 76:301–302
Uter W, Geier J, Bauer A, Schnuch A (2013) Risk factors associated with methylisothiazolinone contact sensitization. Contact Dermatitis 69:231–238
Uter W, Yazar K, Kratz EM, Mildau G, Lidén C (2014) Coupled exposure to ingredients of cosmetic products: II. Preservatives. Contact Dermatitis 70:219–226
Uter W, Amario-Hita JC, Balato A, Ballmer-Weber B, Bauer A, Belloni Fortina A, Bircher A, Chowdhury MMU, Cooper SM, Dugonik A, Gallo R, Giménez-Arnau A, Johansen JD, John SM, Kieć-Świerczyńska M, Kmecl T, Kręcisz B, Larese Filon F, Mahler V, Pesonen M, Rustemeyer T, Sadowska-Przytocka A, Sánchez-Perez J, Schliemann S, Schuttelaar ML, Simon D, Spiewak R, Valiukeviciene S, Weisshaar E, White IR, Wilkinson SM (2017) European surveillance system on contact allergies (ESSCA): results with the European baseline series, 2013/14. J Eur Acad Dermatol Venereol. https://doi.org/10.1111/jdv.14423. [Epub ahead of print]
Vandevenne A, Vanden Broecke K, Goossens A (2014) Sofa dermatitis caused by methylisothiazolinone in a leather-care product. Contact Dermatitis 71(2):111–113
Vanneste L, Persson L, Zimerson E, Bruze M, Luyckx R, Goossens A (2013) Allergic contact dermatitis caused by methylisothiazolinone from different sources, including ‘mislabelled’ household wet wipes. Contact Dermatitis 69:311–312
Venables ZC, Bourke JF, Buckley DA, Campbell F, Chowdhury MM, Abdul-Ghaffar S, Green C, Holden C R, Mcfadden J, Orton D, Sabroe R A, Sansom J, Stone NM, Wakelin SH, Wilkinson SM, Johnston GA (2016) Has the epidemic of allergic contact dermatitis due to methylisothiazolinone reached its peak? Br J Dermatol
Wilkinson JD, Shaw S, Andersen KE, Brandao FM, Bruynzeel DP, Bruze M, Camarasa JM, Diepgen TL, Ducombs G, Frosch PJ, Goossens A, Lachappelle JM, Lahti A, Menné T, Seidenari S, Tosti A, Wahlberg JE (2002) Monitoring levels of preservative sensitivity in Europe. A 10-year overview (1991–2000). Contact Dermatitis 46:207–210
Wilford JE, de Gannes GC (2017) Methylisothiazolinone contact allergy prevalence in Western Canada: increased detection with 2000 ppm patch test allergen. J Cutan Med Surg. https://doi.org/10.1177/1203475417690307. [Epub ahead of print]
Yazar K, Johnsson S, Lind ML, Boman A, Lidén C (2011) Preservatives and fragrances in selected consumer-available cosmetics and detergents. Contact Dermatitis 64:265–272
Yazar K, Lundov MD, Faurschou A, Matura M, Boman A, Johansen JD, Lidén C (2015) Methylisothiazolinone in rinse-off products causes allergic contact dermatitis: a repeated open-application study. Br J Dermatol 173:115–122
Zirwas MJ, Hamann D, Warshaw EM, Maibach HI, Taylor JS, Sasseville D, DeKoven JG, Fransway AF, Mathias CGT, Zug KA, DeLeo VA, Fowler JF, Marks JG, Pratt MD, Belsito DV (2017) Epidemic of isothiazolinone allergy in North America: prevalence data from the North American Contact Dermatitis Group, 2013–2014. Dermatitis 28(3):204–209. https://doi.org/10.1097/DER.0000000000000288
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this entry
Cite this entry
Schwensen, J.F., Johansen, J.D. (2018). Isothiazolinones. In: John, S., Johansen, J., Rustemeyer, T., Elsner, P., Maibach, H. (eds) Kanerva’s Occupational Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-40221-5_216-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-40221-5_216-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40221-5
Online ISBN: 978-3-319-40221-5
eBook Packages: Springer Reference MedicineReference Module Medicine